The groundbreaking treatment of this peptide represents a significant development in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets multiple pathways – glucagon-like peptide-1 https://tirzepatidepeptide499527.newsbloger.com/42638017/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment